The effect of insulin treatment on liver fat content and liver enzymes in individuals with uncontrolled type 2 diabetes and NAFLD has not been extensively studied and no prospective trial has examined its effect on liver histology (Table 6). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.